Biocryst Pharmaceuticals Stock Price, News & Analysis
BCRX
NASDAQ
Company Description
Welcome to the overview page for Biocryst Pharmaceuticals (BCRX), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
$7.62
-0.13%
0.01
Last updated: December 29, 2025 at 10:38
-1.17 %
Performance 1 year
$1.6B
210.7M
Latest News
SEC Filings
Insider Radar
Net Sellers
90-Day Summary
0
Shares Bought
30,810
Shares Sold
2
Transactions
Most Recent Transaction
Barnes Alane P
(Chief Legal Officer)
sold
21,210 shares
@ $7.65
on Dec 15, 2025
Based on SEC Form 4 filings over the last 90 days.
Financial Highlights
$450,712,000
Revenue (TTM)
-$88,881,000
Net Income (TTM)
-$0.43
-$52,020,000
Operating Cash Flow
-19.72%
-0.56%
Upcoming Events
DEC
31
JAN
01
January 1, 2026 - March 31, 2026
Corporate
Astria acquisition closing
Expected closing of Astria Therapeutics acquisition per definitive agreement
JAN
01
MAR
03
March 3, 2026
Corporate
First RSU vesting
APR
01
April 1, 2026
Financial
First RSU vesting installment
MAY
01
May 1, 2026
Corporate
First RSU vesting installment
MAR
03
March 3, 2027
Corporate
Second RSU vesting
APR
01
April 1, 2027
Financial
Second RSU vesting installment
MAY
01
May 1, 2027
Corporate
Second RSU vesting installment
MAR
03
March 3, 2028
Corporate
Third RSU vesting
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of Biocryst Pharmaceuticals (BCRX)?
The current stock price of Biocryst Pharmaceuticals (BCRX) is $7.63 as of December 26, 2025.
What is the market cap of Biocryst Pharmaceuticals (BCRX)?
The market cap of Biocryst Pharmaceuticals (BCRX) is approximately 1.6B. Learn more about what market capitalization means .
What is the revenue (TTM) of Biocryst Pharmaceuticals (BCRX) stock?
The trailing twelve months (TTM) revenue of Biocryst Pharmaceuticals (BCRX) is $450,712,000.
What is the net income of Biocryst Pharmaceuticals (BCRX)?
The trailing twelve months (TTM) net income of Biocryst Pharmaceuticals (BCRX) is -$88,881,000.
What is the earnings per share (EPS) of Biocryst Pharmaceuticals (BCRX)?
The diluted earnings per share (EPS) of Biocryst Pharmaceuticals (BCRX) is -$0.43 on a trailing twelve months (TTM) basis. Learn more about EPS .
What is the operating cash flow of Biocryst Pharmaceuticals (BCRX)?
The operating cash flow of Biocryst Pharmaceuticals (BCRX) is -$52,020,000. Learn about cash flow.
What is the profit margin of Biocryst Pharmaceuticals (BCRX)?
The net profit margin of Biocryst Pharmaceuticals (BCRX) is -19.72%. Learn about profit margins.
What is the operating margin of Biocryst Pharmaceuticals (BCRX)?
The operating profit margin of Biocryst Pharmaceuticals (BCRX) is -0.56%. Learn about operating margins.
What is the gross margin of Biocryst Pharmaceuticals (BCRX)?
The gross profit margin of Biocryst Pharmaceuticals (BCRX) is 97.28%. Learn about gross margins.
What is the current ratio of Biocryst Pharmaceuticals (BCRX)?
The current ratio of Biocryst Pharmaceuticals (BCRX) is 2.63, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the gross profit of Biocryst Pharmaceuticals (BCRX)?
The gross profit of Biocryst Pharmaceuticals (BCRX) is $438,443,000 on a trailing twelve months (TTM) basis.
What is the operating income of Biocryst Pharmaceuticals (BCRX)?
The operating income of Biocryst Pharmaceuticals (BCRX) is -$2,543,000. Learn about operating income.